BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 10224211)

  • 1. Neuroblastoma of the urinary bladder, preclinically detected by mass screening.
    Yokoyama S; Hirakawa H; Ueno S; Yabe H; Hiraoka N
    Pediatrics; 1999 May; 103(5):e67. PubMed ID: 10224211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass screening and age-specific incidence of neuroblastoma in Saitama Prefecture, Japan.
    Yamamoto K; Hayashi Y; Hanada R; Kikuchi A; Ichikawa M; Tanimura M; Yoshioka S
    J Clin Oncol; 1995 Aug; 13(8):2033-8. PubMed ID: 7636545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
    Okazaki T; Kohno S; Mimaya J; Hasegawa S; Urushihara N; Yoshida A; Kawano S; Kusafuka J; Horikoshi Y; Takashima Y; Aoki K; Hamazaki M
    Pediatr Surg Int; 2004 Jan; 20(1):27-32. PubMed ID: 14689211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for neuroblastoma: a review of the evidence.
    Chamberlain J
    J Med Screen; 1994 Jul; 1(3):169-75. PubMed ID: 8790511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
    Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
    Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder origin neuroblastoma detected by mass screening.
    Ijiri R; Tanaka Y; Kou K; Nishihira H; Nishi T
    Urology; 1998 Dec; 52(6):1139-41. PubMed ID: 9836572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural course of neuroblastoma detected by mass screening: s 5-year prospective study at a single institution.
    Nishihira H; Toyoda Y; Tanaka Y; Ijiri R; Aida N; Takeuchi M; Ohnuma K; Kigasawa H; Kato K; Nishi T
    J Clin Oncol; 2000 Aug; 18(16):3012-7. PubMed ID: 10944135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One hundred neuroblastomas detected through a mass screening system in Japan.
    Hachitanda Y; Ishimoto K; Hata J; Shimada H
    Cancer; 1994 Dec; 74(12):3223-6. PubMed ID: 7982186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening study group.
    Sawada T; Hirayama M; Nakata T; Takeda T; Takasugi N; Mori T; Maeda K; Koide R; Hanawa Y; Tsunoda A
    Lancet; 1984 Aug; 2(8397):271-3. PubMed ID: 6146820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based study of the usefulness of screening for neuroblastoma.
    Woods WG; Tuchman M; Robison LL; Bernstein M; Leclerc JM; Brisson LC; Brossard J; Hill G; Shuster J; Luepker R; Byrne T; Weitzman S; Bunin G; Lemieux B
    Lancet; 1996 Dec 21-28; 348(9043):1682-7. PubMed ID: 8973429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children.
    Bessho F; Hashizume K; Nakajo T; Kamoshita S
    J Pediatr; 1991 Aug; 119(2):237-41. PubMed ID: 1861208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of neuroblastoma in infancy in Japan.
    Sawada T; Kidowaki T; Sugimoto T; Kusunoki T
    Med Pediatr Oncol; 1984; 12(2):101-3. PubMed ID: 6700544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
    Suita S; Zaizen Y; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Ueda K; Tasaka H; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Yano H; Akiyama H; Ikeda K
    J Pediatr Surg; 1996 Apr; 31(4):555-8. PubMed ID: 8801312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Past and future of neuroblastoma screening in Japan.
    Sawada T
    Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):320-6. PubMed ID: 1456397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The urinary bladder: An extremely rare location of pediatric neuroblastoma.
    Entz-Werle N; Marcellin L; Becmeur F; Eyer D; Babin-Boilletot A; Lutz P
    J Pediatr Surg; 2003 Aug; 38(8):E10-2. PubMed ID: 12891516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence and possible progression of a pelvic neuroblastoma detected by mass screening during 19 months.
    Bernstein ML; Azouz EM; Woods W; Tuchman M; Renaud L; Lemieux B
    Am J Pediatr Hematol Oncol; 1994 May; 16(2):164-6. PubMed ID: 8166370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass screening of neuroblastoma in Sapporo City, Japan.
    Nishi M; Miyake H; Takeda T; Kikuchi Y; Hanai J; Yonemori H; Takasugi N
    Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):327-31. PubMed ID: 1456398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problems of neuroblastoma screening for 6 month olds and results of second screening for 18 month olds.
    Hayashi Y; Ohi R; Yaoita S; Nakamura M; Kikuchi Y; Konno T; Tsuchiya S; Shiraishi H
    J Pediatr Surg; 1995 Mar; 30(3):467-70. PubMed ID: 7760244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of mass screening for neuroblastoma in 18-month-old infants in Osaka area, Japan.
    Yamamichi T; Oue T; Irie A; Inoue M; Takama Y; Nomura M; Yoneda A; Okuyama H; Usui N
    Pediatr Surg Int; 2021 Dec; 37(12):1645-1649. PubMed ID: 34519853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for neuroblastoma in North America. Preliminary results of a pathology review from the Quebec Project.
    Takeuchi LA; Hachitanda Y; Woods WG; Tuchman M; Lemieux B; Brisson L; Bernstein M; Brossard J; Leclerc JM; Byrne TD
    Cancer; 1995 Dec; 76(11):2363-71. PubMed ID: 8635044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.